Skip to main content
Top
Published in: Quality of Life Research 7/2016

27-11-2015

Interpretation of Renal Quality of Life Profile scores in routine clinical practice: an aid to treatment decision-making

Authors: Nadine Aawar, Richard Moore, Stephen Riley, Sam Salek

Published in: Quality of Life Research | Issue 7/2016

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

Purpose

High Renal Quality of Life Profile (RQLP) scores are associated with impaired health-related quality of life; however, the clinical meaning of the scores is difficult for clinicians and healthcare planners to interpret. The aim of this study was to determine clinical significance of RQLP scores which could be used to aid clinical decision-making.

Methods

The anchor-based technique (a method for categorizing numeric scores to ease interpretation) was used to develop a categorization system for the RQLP scores using a global question (GQ). The GQ scores (i.e. no effect to extremely large effect) were mapped against the RQLP scores, and intraclass correlation coefficient (ICC) was used to test their agreement. The RQLP and the GQ were administered to 260 adult patients (males = 165 and females = 95) with chronic renal failure (CRF).

Results

The mean RQLP score was 67.2, median = 61, SD = 41.5, and range 0–172. The mean GQ score was 1.74, median = 2, SD = 1.27, and range 0–4. The mean, mode, and median of the GQ scores for each RQLP score were used to devise several sets of categories of RQLP score, and the ICC test of agreement was calculated. The proposed set of RQLP score banding for adoption includes: 0–20 = no effect on patient’s life (GQ = 0, n = 35); 21–51 = small effect on patient’s life (GQ = 1, n = 66); 52–93 = moderate effect on patient’s life (GQ = 2, n = 87); 94–134 = very large effect on patient’s life (GQ = 3, n = 54); and 135–172 = extremely large effect on patient’s life (GQ = 4, n = 18). The ICC coefficient for the proposed banding system was 0.80.

Conclusion

The proposed categorization of the RQLP will aid the clinical interpretation of change in RQLP score informing treatment decision-making in routine practice.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Literature
1.
go back to reference Crosby, R. D., Kolotkin, R. L., & Williams, G. R. (2001). Defining clinically meaningful change in health related quality of life. Value Health, 4, 177.CrossRef Crosby, R. D., Kolotkin, R. L., & Williams, G. R. (2001). Defining clinically meaningful change in health related quality of life. Value Health, 4, 177.CrossRef
2.
go back to reference Lydick, E., & Epstein, R. S. (1993). Interpretation of quality of life changes. Quality of Life Research, 2, 221–226.CrossRefPubMed Lydick, E., & Epstein, R. S. (1993). Interpretation of quality of life changes. Quality of Life Research, 2, 221–226.CrossRefPubMed
3.
go back to reference Salek, M. S. (2000). Renal quality of life profile user manual. Oxford: Oxford Outcomes. Salek, M. S. (2000). Renal quality of life profile user manual. Oxford: Oxford Outcomes.
4.
go back to reference Testa, M. A. (2000). Interpretation of quality-of-life outcomes: Issues that affect magnitude and meaning. Medical Care, 38, 166–174.CrossRef Testa, M. A. (2000). Interpretation of quality-of-life outcomes: Issues that affect magnitude and meaning. Medical Care, 38, 166–174.CrossRef
5.
go back to reference Hongbo, Y., Thomas, C. L., Harrison, M. A., Salek, M. S., & Finlay, A. Y. (2005). Translating the science of quality of life into practice: What do dermatology life quality index scores mean? Journal of Investigative Dermatology, 125, 659–664.CrossRefPubMed Hongbo, Y., Thomas, C. L., Harrison, M. A., Salek, M. S., & Finlay, A. Y. (2005). Translating the science of quality of life into practice: What do dermatology life quality index scores mean? Journal of Investigative Dermatology, 125, 659–664.CrossRefPubMed
6.
go back to reference Juniper, E. F., Guyatt, G. H., Griffith, L. E., & Ferrie, P. J. (1996). Interpretation of rhinoconjunctivitis quality of life questionnaire data. The Journal of Allergy and Clinical Immunology, 98, 843–845.CrossRefPubMed Juniper, E. F., Guyatt, G. H., Griffith, L. E., & Ferrie, P. J. (1996). Interpretation of rhinoconjunctivitis quality of life questionnaire data. The Journal of Allergy and Clinical Immunology, 98, 843–845.CrossRefPubMed
7.
go back to reference Prinsen, C. A. C., Lindeboom, R., Sprangers, M. A. G., Legierse, C. M., & de Korte, J. (2010). Health-related quality of life assessment in dermatology: Interpretation of skindex-29 scores using patient-based anchors. Journal of Investigative Dermatology, 130, 1318–1322.CrossRefPubMed Prinsen, C. A. C., Lindeboom, R., Sprangers, M. A. G., Legierse, C. M., & de Korte, J. (2010). Health-related quality of life assessment in dermatology: Interpretation of skindex-29 scores using patient-based anchors. Journal of Investigative Dermatology, 130, 1318–1322.CrossRefPubMed
8.
go back to reference Salek, S. (1999). Quality of life in patients with end-stage renal disease. Journal of Applied Therapeutic Research, 2, 163–170. Salek, S. (1999). Quality of life in patients with end-stage renal disease. Journal of Applied Therapeutic Research, 2, 163–170.
9.
go back to reference Guyatt, G. H., Osoba, D., Wu, A. W., Wyrwich, K. W., & Norman, G. R. (2002). Methods to explain the clinical significance of health status measures. Mayo Clinic Proceedings, 77, 371–383.CrossRefPubMed Guyatt, G. H., Osoba, D., Wu, A. W., Wyrwich, K. W., & Norman, G. R. (2002). Methods to explain the clinical significance of health status measures. Mayo Clinic Proceedings, 77, 371–383.CrossRefPubMed
11.
go back to reference Rosner, B. (2010). Fundamentals of biostatistics (7th ed.). New York, NY: Duxbury Press. Rosner, B. (2010). Fundamentals of biostatistics (7th ed.). New York, NY: Duxbury Press.
12.
go back to reference Rettig, R. A., Sadler, J. H., Meyer, K. B., Wasson, J. H., Parkerson, G. R, Jr, Kantz, B., et al. (1997). Assessing health and quality of life outcomes in dialysis: A report on an Institute of Medicine workshop. American Journal of Kidney Diseases, 30, 140–155.CrossRefPubMed Rettig, R. A., Sadler, J. H., Meyer, K. B., Wasson, J. H., Parkerson, G. R, Jr, Kantz, B., et al. (1997). Assessing health and quality of life outcomes in dialysis: A report on an Institute of Medicine workshop. American Journal of Kidney Diseases, 30, 140–155.CrossRefPubMed
14.
go back to reference Solari, A. (2005). Role of health-related quality of life measures in the routine care of people with multiple sclerosis. Health and Quality of Life Outcomes, 3(1), 16.CrossRefPubMedPubMedCentral Solari, A. (2005). Role of health-related quality of life measures in the routine care of people with multiple sclerosis. Health and Quality of Life Outcomes, 3(1), 16.CrossRefPubMedPubMedCentral
15.
go back to reference Velikova, G., Booth, L., Smith, A. B., Brown, P. M., Lynch, P., Brown, J. M., et al. (2004). Measuring quality of life in routine oncology practice improves communication and patient well-being: A randomized controlled trial. Journal of Clinical Oncology, 22, 714–724.CrossRefPubMed Velikova, G., Booth, L., Smith, A. B., Brown, P. M., Lynch, P., Brown, J. M., et al. (2004). Measuring quality of life in routine oncology practice improves communication and patient well-being: A randomized controlled trial. Journal of Clinical Oncology, 22, 714–724.CrossRefPubMed
16.
go back to reference Deyo, R. A., & Patrick, D. L. (1995). The significance of treatment effects: The clinical perspective. Medical Care, 33, AS286–AS291.PubMed Deyo, R. A., & Patrick, D. L. (1995). The significance of treatment effects: The clinical perspective. Medical Care, 33, AS286–AS291.PubMed
17.
go back to reference Chren, M. M. (2005). Measurement of vital signs for skin diseases. Journal of Investigative Dermatology, 125(4), viii–ix.CrossRefPubMed Chren, M. M. (2005). Measurement of vital signs for skin diseases. Journal of Investigative Dermatology, 125(4), viii–ix.CrossRefPubMed
Metadata
Title
Interpretation of Renal Quality of Life Profile scores in routine clinical practice: an aid to treatment decision-making
Authors
Nadine Aawar
Richard Moore
Stephen Riley
Sam Salek
Publication date
27-11-2015
Publisher
Springer International Publishing
Published in
Quality of Life Research / Issue 7/2016
Print ISSN: 0962-9343
Electronic ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-015-1191-4

Other articles of this Issue 7/2016

Quality of Life Research 7/2016 Go to the issue